ALXO
Alx Oncology Holdings
NASDAQ: ALXO · HEALTHCARE · BIOTECHNOLOGY
$1.70
+7.59% today
Updated 2026-04-30
Market cap
$212.60M
P/E ratio
—
P/S ratio
5,085.96x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$0 – $3
Volume
1.0M
Alx Oncology Holdings (ALXO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-145.70%
ROA
-61.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $2.07M | $-13.73M | 9.05% | -662.02% | -664.30% |
| 2019 | $4.80M | $-19.24M | 9.09% | -399.98% | -401.23% |
| 2020 | $1.18M | $-45.74M | 9.05% | -3,693.99% | -3,869.71% |
| 2021 | $0.00 | $-83.46M | — | — | — |
| 2022 | $0.00 | $-123.48M | — | — | — |
| 2023 | $0.00 | $-160.81M | — | — | — |
| 2024 | $0.00 | $-134.85M | — | — | — |
| 2025 | $0.00 | $-101.69M | — | — | — |